Nanodelivery systems and stabilized solid-drug nanoparticles for orally administered medicine: current landscape

References

• da SilvaALCruzFFRoccoPRMMoralesMMNew perspectives in nanotherapeutics for chronic respiratory diseasesBiophys Rev20179579380328914424
   PubMedGoogle Scholar
• WenRBanikBPathakRKKumarAKolishettiNDharSNanotechnology inspired tools for mitochondrial dysfunction related diseasesAdv Drug Deliv Rev201699Pt A526926776231
   PubMedGoogle Scholar
• PathakKRaghuvanshiSOral bioavailability: issues and solutions via nanoformulationsClin Pharmacokinet201554432535725666353
   PubMed Web of Science ®Google Scholar
• BaruaSMitragotriSChallenges associated with penetration of nano-particles across cell and tissue barriers: A review of current status and future prospectsNano Today20149222324325132862
   PubMed Web of Science ®Google Scholar
• JmYYjLQiuLYJinYPolymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterizationJ Pharm Pharmacol20096171371919505361
   PubMed Web of Science ®Google Scholar
• JohnstonHBrownDKermanizadehAGubbinsEStoneVInvestigating the relationship between nanomaterial hazard and physicochemical properties: Informing the exploitation of nanomaterials within therapeutic and diagnostic applicationsJ Control Release2012164330731322940205
   PubMed Web of Science ®Google Scholar
• DingCLiZA review of drug release mechanisms from nanocarrier systemsMater Sci Eng C Mater Biol Appl2017761440145328482511
   PubMed Web of Science ®Google Scholar
• KermanizadehAJantzenKBrownDMMøllerPLoftSA flow cytometry-based method for the screening of nanomaterial-induced reactive oxygen species production in leukocytes subpopulations in whole bloodBasic Clin Pharmacol Toxicol2018122114915628691406
   PubMed Web of Science ®Google Scholar
• LanoneSAndujarPKermanizadehABoczkowskiJDeterminants of carbon nanotube toxicityAdv Drug Deliv Rev201365152063206923928473
   PubMed Web of Science ®Google Scholar
• Vega-VilaKRTakemotoJKYanezJARemsbergCMForrestMLDaviesNMClinical toxicities of nanocarrier systemsAdv Drug Deliv Rev20086092993818313790
   PubMed Web of Science ®Google Scholar
• ShenXLiTChenZLuminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranosticsInt J Nanomedicine2017124299432228652734
   PubMed Web of Science ®Google Scholar
• KermanizadehAVilladsenKØstremRGJensenKJMøllerPLoftSIntegrin targeting and toxicological assessment of peptide-conjugated liposome delivery systems to activated endothelial cellsBasic Clin Pharmacol Toxicol2017120438038927767251
   PubMed Web of Science ®Google Scholar
• GrimaldiAMIncoronatoMSalvatoreMSoricelliANanoparticle-based strategies for cancer immunotherapy and immunodiagnosticsNanomedicine201712192349236528868980
   PubMed Web of Science ®Google Scholar
• SilvaACSantosDFerreiraDLopesCMLipid-based nanocarriers as an alternative for oral delivery of poorly water-soluble drugs: peroral and mucosal routesCurr Med Chem201219264495451022834821
   PubMed Web of Science ®Google Scholar
• de SioLCaraccioloGPlacidoTApplications of nanomaterials in modern medicineRendiconti Lincei201526S2231237
   Google Scholar
• TathamLMRannardSPOwenANanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeuticsTher Deliv20156446949025996045
   PubMedGoogle Scholar
• BraakhuisHMKloetSKKezicSProgress and future of in vitro models to study translocation of nanoparticlesArch Toxicol20158991469149525975987
   PubMed Web of Science ®Google Scholar
• RichardJChallenges in oral peptide delivery: lessons learnt from the clinic and future prospectsTher Deliv20178866368428730934
   PubMed Web of Science ®Google Scholar
• PowellJJFariaNThomas-MckayEPeleLCOrigin and fate of dietary nanoparticles and microparticles in the gastrointestinal tractJ Autoimmun2010343J226J23320096538
   PubMed Web of Science ®Google Scholar
• PanyalaAChindeSKumariSIGroverPAssessment of genotoxicity and biodistribution of nano- and micron-sized yttrium oxide in rats after acute oral treatmentJ Appl Toxicol201737121379139528685832
   PubMed Web of Science ®Google Scholar
• FröhlichERobleggEOral uptake of nanoparticles: human relevance and the role of in vitro systemsArch Toxicol201690102297231427342244
   PubMed Web of Science ®Google Scholar
• World Health Organisation International classification of disease, 11th version Available from: http://www.who.int/classifications/icd/en/Accessed July 18, 2018
   Google Scholar
• ThamphiwatanaSGaoWObonyoMZhangLIn vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammationProc Natl Acad Sci U S A201411149176001760525422427
   PubMed Web of Science ®Google Scholar
• AlaiMLinWJApplication of nanoparticles for oral delivery of acid-labile lansoprazole in the treatment of gastric ulcer: in vitro and in vivo evaluationsInt J Nanomedicine2015104029404126124659
   PubMed Web of Science ®Google Scholar
• XiaoBLarouiHViennoisENanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in miceGastroenterology201414651289130024503126
   PubMed Web of Science ®Google Scholar
• MoulariBPertuitDPellequerYLamprechtAThe targeting of surface modified silica nanoparticles to inflamed tissue in experimental colitisBiomaterials200829344554456018790531
   PubMed Web of Science ®Google Scholar
• BevivinoGMonteleoneGAdvances in understanding the role of cytokines in inflammatory bowel diseaseExpert Rev Gastroenterol Hepatol201812990791530024302
   PubMed Web of Science ®Google Scholar
• GreishKTahaSJasimAStyrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel diseaseClin Transl Med2017612828770521
   PubMedGoogle Scholar
• ChenYLiuJYangXZhaoXXuHOleanolic acid nanosuspensions: preparation, in-vitro characterization and enhanced hepatoprotective effectJ Pharm Pharmacol200557225926415720792
   PubMed Web of Science ®Google Scholar
• DingXYHongCJLiuYTissue distribution, and metabolites of a polyvinylpyrrolidone coated norcantharidin chitosan nanoparticle formulation in rats and mice, using LC-MS/MSInt J Nanomedicine201271723173522619523
   PubMed Web of Science ®Google Scholar
• ZhangHPLiGQGuoWZOridonin synergistically enhances JQ1-triggered apoptosis in hepatocellular cancer cells through mitochondrial pathwayOncotarget201786310683310684329290992
   PubMedGoogle Scholar
• LiuYLiuJLiangJMucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of ori-doninNanomedicine20171372219222928539275
   PubMed Web of Science ®Google Scholar
• NekkantiVRuedaJWangZBetageriGVComparative evaluation of proliposomes and self micro-emulsifying drug delivery system for improved oral bioavailability of nisoldipineInt J Pharm20165051–2798827041124
   PubMedGoogle Scholar
• KrishnamoorthyBHabibur RahmanSMTamil SelvanNDesign, formulation, in vitro, in vivo, and pharmacokinetic evaluation of nisoldipine-loaded self-nanoemulsifying drug delivery systemJ Nanoparticle Res201517134
   Web of Science ®Google Scholar
• BegSSharmaGThankiKJainSKatareOPSinghBPositively charged self-nanoemulsifying oily formulations of olmesartan medox-omil: Systematic development, in vitro, ex vivo and in vivo evaluationInt J Pharm20154931–246648226211900
   PubMedGoogle Scholar
• QiRZhangHXuLG5 PAMAM dendrimer versus liposome: A comparison study on the in vitro transepithelial transport and in vivo oral absorption of simvastatinNanomedicine20151151141115125791813
   PubMed Web of Science ®Google Scholar
• LzLTongCQYuJHanMGaoJQMechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticlesInt J Nanomedicine201382709271723935363
   PubMed Web of Science ®Google Scholar
• PerroneDArditoFGiannatempoGBiological and therapeutic activities, and anticancer properties of curcuminExp Ther Med20151051615162326640527
   PubMed Web of Science ®Google Scholar
• SunMZhaoLGuoCEvaluation of an oral carrier system in rats: bioavailability and gastrointestinal absorption properties of curcumin encapsulated PBCA nanoparticlesJ Nanoparticle Res2012142705
   Web of Science ®Google Scholar
• SunWZouYGuoYConstruction and characterization of curcumin nanoparticles systemJ Nanoparticle Res20141632317
   Web of Science ®Google Scholar
• HarigaeTNakagawaKMiyazawaTMetabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administrationInt J Nanomedicine2016113009302227418823
   PubMed Web of Science ®Google Scholar
• KimMSSoluplus-coated colloidal silica nanomatrix system for enhanced supersaturation and oral absorption of poorly water-soluble drugsArtif Cells Nanomed Biotechnol201341636336723336707
   PubMed Web of Science ®Google Scholar
• ZhangZHZhangYLZhouJPHxLSolid lipid nanoparticles modified with stearic acid-octaarginine for oral administration of insulinInt J Nanomedicine201273333333922848162
   PubMed Web of Science ®Google Scholar
• LiuJYangKXiaoWGLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent mannerPeptides2018106839030003931
   PubMed Web of Science ®Google Scholar
• QuWLiYHovgaardLA silica-based pH-sensitive nano-matrix system improves the oral absorption and efficacy of incre-tin hormone glucagon-like peptide-1Int J Nanomedicine201274983499423028226
   PubMed Web of Science ®Google Scholar
• TranKLParkYIPandyaSOverview of glucagon-like peptide-1 receptor agonists for the treatment of patients with type 2 diabetesAm Health Drug Benefits20171017818828794822
   PubMed Web of Science ®Google Scholar
• LiXWangCLiangRThe glucose-lowering potential of exenatide delivered orally via goblet cell-targeting nanoparticlesPharm Res2015321017102725270570
   PubMed Web of Science ®Google Scholar
• XiongXYLiQHLiYPGuoLLiZLGongYCPluronic P85/poly(lactic acid) vesicles as novel carrier for oral insulin deliveryColloids Surf B Biointerfaces201311128228823838194
   PubMed Web of Science ®Google Scholar
• RafieiPHaddadiAPharmacokinetic consequences of PLGA nano-particles in Docetaxel drug deliveryPharm Nanotechnol20175132328948907
   PubMedGoogle Scholar
• PicardMManagement of Hypersensitivity Reactions to TaxanesImmunol Allergy Clin North Am201737467969328965634
   PubMed Web of Science ®Google Scholar
• ChoHJParkJWYoonISKimDDSurface-modified solid lipid nano-particles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptakeInt J Nanomedicine2014949550424531717
   PubMed Web of Science ®Google Scholar
• HuKCaoSHuFFengJEnhanced oral bioavailability of docetaxel by lecithin nanoparticles: preparation, in vitro, and in vivo evaluationInt J Nanomedicine201273537354522848177
   PubMed Web of Science ®Google Scholar
• LiuYZhaiYHanXBioadhesive chitosan-coated cyclodextrin-based superamolecular nanomicelles to enhance the oral bioavailability of doxorubicinJ Nanoparticle Res201416102587
   Web of Science ®Google Scholar
• EloyJOPetrilliRChescaDLSaggioroFPLeeRJMarchettiJMAnti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapyEur J Pharm Biopharm201711515916728257810
   PubMed Web of Science ®Google Scholar
• LiuFParkJYZhangYTargeted cancer therapy with novel high drug-loading nanocrystalsJ Pharm Sci20109983542355120564383
   PubMed Web of Science ®Google Scholar
• ZhaoLFengSSEnhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studiesJ Pharm Sci20109983552356020564384
   PubMed Web of Science ®Google Scholar
• ZengNGaoXHuQLipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorptionInt J Nanomedicine201273703371822888230
   PubMed Web of Science ®Google Scholar
• LiuCLiuDBaiFZhangJZhangNIn vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil deliveryDrug Deliv201017535236320387993
   PubMed Web of Science ®Google Scholar
• LiuDLiuCZouWZhangNEnhanced gastrointestinal absorption of N3-O-toluyl-fluorouracil by cationic solid lipid nanoparticlesJ Nanoparticle Res2010123975984
   Web of Science ®Google Scholar
• SagnellaSMGongXMoghaddamMJNanostructured nanoparticles of self-assembled lipid pro-drugs as a route to improved chemotherapeutic agentsNanoscale20113391992421173998
   PubMed Web of Science ®Google Scholar
• NasrinAHassanMYePInhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cellsBiochem Biophys Res Commun201849532118212429253571
   PubMed Web of Science ®Google Scholar
• DesaiDPrabhakarNMamaevaVTargeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticlesInt J Nanomedicine20161129931326855569
   PubMed Web of Science ®Google Scholar
• KawamotoRYamashitaANishihiraKDifferent inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbitsPathol Res Pract2006202644745616635553
   PubMed Web of Science ®Google Scholar
• ZhangZCaoHJiangSNanoassembly of probucol enables novel therapeutic efficacy in the suppression of lung metastasis of breast cancerSmall201410224735474524930590
   PubMed Web of Science ®Google Scholar
• BoakyeCHPatelKPatelARLipid-based oral delivery systems for skin deposition of a potential chemopreventive DIM derivative: characterization and evaluationDrug Deliv Transl Res20166552653927405772
   PubMed Web of Science ®Google Scholar
• PangeniRChoiSWJeonOCByunYParkJWMultiple nanoemulsion system for an oral combinational delivery of oxaliplatin and 5-fluorouracil: preparation and in vivo evaluationInt J Nanomedicine2016116379639927942212
   PubMed Web of Science ®Google Scholar
• SandhuPSKumarRBegSNatural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and narin-genin: Systematic approach for improved breast cancer therapeuticsNanomedicine20171351703171328343014
   PubMed Web of Science ®Google Scholar
• JinXZhangZSunEEnhanced oral absorption of 20(S)-protopanaxadiol by self-assembled liquid crystalline nanoparticles containing piperine: in vitro and in vivo studiesInt J Nanomedicine2013864165223426652
   PubMed Web of Science ®Google Scholar
• ZhangZLiMWangHAgrawalSZhangRAntisense therapy targeting MDM2 oncogene in prostate cancer: effects on proliferation, apoptosis, multiple gene expression, and chemotherapyPNAS2003100116361164113130078
   PubMed Web of Science ®Google Scholar
• VorugantiSQinJJSarkarSOral nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of actionOncotarget20156213792139426041888
   PubMedGoogle Scholar
• ChenWLYuanZQLiuYLiposomes coated with N-trimethyl chitosan to improve the absorption of harmine in vivo and in vitroInt J Nanomedicine20161132533626855571
   PubMed Web of Science ®Google Scholar
• DangHMengMHWZhaoHLuteolin-loaded solid lipid nanoparticles synthesis, characterization, & improvement of bioavailability, pharmacokinetics in vitro and vivo studiesJ Nanoparticle Res20141642347
   Web of Science ®Google Scholar
• ShaSVongLBChonpathompikunlertPYoshitomiTMatsuiHNagasakiYSuppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticlesBiomaterials201334338393840023896000
   PubMed Web of Science ®Google Scholar
• HillaireauHDereuddre-BosquetNSkanjiRAnti-HIV efficacy and biodistribution of nucleoside reverse transcriptase inhibitors delivered as squalenoylated prodrug nanoassembliesBiomaterials201334204831483823562054
   PubMed Web of Science ®Google Scholar
• JinYXinRTongLduLLiMCombination anti-HIV therapy with the self-assemblies of an asymmetric bolaamphiphilic zidovudine/didanosine prodrugMol Pharm20118386787621553876
   PubMedGoogle Scholar
• McdonaldTOGiardielloMMartinPAntiretroviral solid drug nanoparticles with enhanced oral bioavailability: production, characterization, and in vitro-in vivo correlationAdv Healthc Mater20143340041123997027
   PubMed Web of Science ®Google Scholar
• SkanjiRAndrieuxKLalanneMA new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuaryInt J Pharm20114141–228529721596125
   PubMedGoogle Scholar
• TshweuLKatataLKalomboLEnhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying methodNanomedicine20149121821183324364871
   PubMed Web of Science ®Google Scholar
• SerranoDRLalatsaADea-AyuelaMAOral particle uptake and organ targeting drives the activity of amphotericin B nanoparticlesMol Pharm201512242043125558881
   PubMed Web of Science ®Google Scholar
• OmwoyoWNOgutuBOlooFPreparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticlesInt J Nanomedicine201493865387425143734
   PubMed Web of Science ®Google Scholar
• ZhangCPengFLiuWNanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male ratsInt J Nanomedicine201491049106324591827
   PubMed Web of Science ®Google Scholar
• QiaoHChenLRuiTFabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by d-α-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfateInt J Nanomedicine2017121033104628223797
   PubMed Web of Science ®Google Scholar
• YinJXiangCWangPYinYHouYBiocompatible nanoemulsions based on hemp oil and less surfactants for oral delivery of baicalein with enhanced bioavailabilityInt J Nanomedicine2017122923293128435268
   PubMed Web of Science ®Google Scholar
• EissaMMEl-MoslemanyRMRamadanAAAmerEIEl-AzzouniMZEl-KhordaguiLKMiltefosine lipid nanocapsules for single dose oral treatment of Schistosomiasis Mansoni: a preclinical studyPLoS One20151011e014178826574746
   PubMed Web of Science ®Google Scholar
• CamachoAIIracheJMde SouzaJSánchez-GómezSGamazoCNanoparticle-based vaccine for mucosal protection against Shigella flexneri in miceVaccine201331323288329423727423
   PubMed Web of Science ®Google Scholar
• LewittPALevodopa therapy for Parkinson’s disease: Pharmacokinetics and pharmacodynamicsMov Disord2015301647225449210
   PubMed Web of Science ®Google Scholar
• KuraAUCheahPSHusseinMZToxicity evaluation of zinc aluminium levodopa nanocomposite via oral route in repeated dose studyNanoscale Res Lett20149126124948886
   PubMedGoogle Scholar
• ChonpathompikunlertPYoshitomiTVongLBImaizumiNOzakiYNagasakiYRecovery of cognitive dysfunction via orally administered redox-polymer nanotherapeutics in SAMP8 micePLoS One2015105e012601325955022
   PubMed Web of Science ®Google Scholar
• TosiGRuoziBBellettiDBrain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodentsNanomedicine2013891373138323565661
   PubMed Web of Science ®Google Scholar
• CheLZhouJLiSAssembled nanomedicines as efficient and safe therapeutics for articular inflammationInt J Pharm20124391–230731622989985
   PubMedGoogle Scholar
• KimuraTA new family of nonsiliceous porous hybrids from bisphosphonatesJ Nanosci Nanotechnol20131342461247023763120
   PubMed Web of Science ®Google Scholar
• JungIWHanHKEffective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterizationInt J Nanomedicine201492299230624872692
   PubMed Web of Science ®Google Scholar
• SkrajnowskaDBobrowska-KorczakBTokarzADisorders of mechanisms of calcium metabolism control as potential risk factors of prostate cancerCurr Med Chem201724384229424428901272
   PubMed Web of Science ®Google Scholar
• HwangSRSeoDHByunYParkJWThe anti-osteoporotic effects of the orally administered nano-complex were evaluated these animals following oral exposure at doses of 50 µg/kgInt J Nanomedicine2016114231424627621618
   PubMedGoogle Scholar
• AbramovECassiolaFSchwobOCellular mechanism of oral absorption of solidified polymer micellesNanomedicine2015111993200226247432
   PubMed Web of Science ®Google Scholar
• JainSHardeHIndulkarAAgrawalAKImproved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administrationNanomedicine20141043144024036099
   PubMed Web of Science ®Google Scholar
• YpLSunLZYaoLHXiongXYZlLAcute and subacute toxicity studies of Pluronic P85/poly (lactic acid) nanoparticles in miceMicro Nano Lett20138796800
   Web of Science ®Google Scholar
• SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine2010666267120230912
   PubMed Web of Science ®Google Scholar
• LeeCMLeeTKKimDIOptical imaging of absorption and distribution of RITC-SiO2 nanoparticles after oral administrationInt J Nanomedicine20149243250
   PubMed Web of Science ®Google Scholar
• Brotons-CantoAGamazoCMartín-ArbellaNEvaluation of nanoparticles as oral vehicles for immunotherapy against experimental peanut allergyInt J Biol Macromol201811032833528965967
   PubMed Web of Science ®Google Scholar
• HeishHLLeeCHLinKCDevelopment of Yam Dioscorin-loaded nanoparticles for paracellular transport across human intestinal Caco-2 cell monolayersJ Agric Food Chem2018711751183
   Google Scholar
• LechugaSIvanovAIDisruption of the epithelial barrier during intestinal inflammation: quest for new molecules and mechanismsBiochim Biophys Acta Mol Cell Res1864201711831194
   Google Scholar
• ChengYEl-KattanAZhangYRayASLaiYInvolvement of drug transporters in organ toxicity: the fundamental basis of drug discovery and developmentChem Res Toxicol201629454556326889774
   PubMed Web of Science ®Google Scholar
• TalattofAPriceJCAmidonGLGastrointestinal motility variation and implications for plasma level variation: oral drug productsMol Pharm201613255756726692042
   PubMedGoogle Scholar
• LopesCMBettencourtCRossiAButtiniFBarataPOverview on gastroretentive drug delivery systems for improving drug bioavailabilityInt J Pharm2016510114415827173823
   PubMed Web of Science ®Google Scholar
• McdermottJScholesPFormulation design space: a proven approach to maximize flexibility and outcomes within early clinical developmentTher Deliv201561112681278
   Google Scholar
• ShekhawatPBPokharkarVBUnderstanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdlesActa Pharm Sin B20177326028028540164
   PubMed Web of Science ®Google Scholar
• WeissigVPettingerTKMurdockNNanopharmaceuticals (part 1): products on the marketInt J Nanomedicine201494357437325258527
   PubMed Web of Science ®Google Scholar
• NguyenVHLeeBJProtein corona: a new approach for nanomedicine designInt J Nanomedicine2017123137315128458536
   PubMed Web of Science ®Google Scholar
• YangLKuangHZhangWAguilarZPWeiHXuHComparisons of the biodistribution and toxicological examinations after repeated intravenous administration of silver and gold nanoparticles in miceSci Rep201771330328607366
   PubMedGoogle Scholar
• HuhYSmithDEFengMRInterspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugsXenobiotica2011411197298721892879
   PubMed Web of Science ®Google Scholar